163 related articles for article (PubMed ID: 11544314)
21. Neutralizing human monoclonal antibodies binding multiple serotypes of botulinum neurotoxin.
Garcia-Rodriguez C; Geren IN; Lou J; Conrad F; Forsyth C; Wen W; Chakraborti S; Zao H; Manzanarez G; Smith TJ; Brown J; Tepp WH; Liu N; Wijesuriya S; Tomic MT; Johnson EA; Smith LA; Marks JD
Protein Eng Des Sel; 2011 Mar; 24(3):321-31. PubMed ID: 21149386
[TBL] [Abstract][Full Text] [Related]
22. Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease.
Miwa K; Hashimoto H; Yatomi T; Nakamura N; Nagata S; Suda T
Int Immunol; 1999 Jun; 11(6):925-31. PubMed ID: 10360966
[TBL] [Abstract][Full Text] [Related]
23. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
[TBL] [Abstract][Full Text] [Related]
24. CD95 (Fas) ligand-expressing vesicles display antibody-mediated, FcR-dependent enhancement of cytotoxicity.
Jodo S; Hohlbaum AM; Xiao S; Chan D; Strehlow D; Sherr DH; Marshak-Rothstein A; Ju ST
J Immunol; 2000 Nov; 165(10):5487-94. PubMed ID: 11067901
[TBL] [Abstract][Full Text] [Related]
25. Expression of a Fas-like proapoptotic molecule on the lymphocytes of Xenopus laevis.
Mangurian C; Johnson RO; McMahan R; Clothier RH; Ruben LN
Immunol Lett; 1998 Nov; 64(1):31-8. PubMed ID: 9865599
[TBL] [Abstract][Full Text] [Related]
26. Epitope mapping of the transforming growth factor-beta superfamily protein, macrophage inhibitory cytokine-1 (MIC-1): identification of at least five distinct epitope specificities.
Fairlie WD; Russell PK; Wu WM; Moore AG; Zhang HP; Brown PK; Bauskin AR; Breit SN
Biochemistry; 2001 Jan; 40(1):65-73. PubMed ID: 11141057
[TBL] [Abstract][Full Text] [Related]
27. Neutralizing activity of antibodies to the V3 loop region of HIV-1 gp120 relative to their epitope fine specificity.
Pantophlet R; Wrin T; Cavacini LA; Robinson JE; Burton DR
Virology; 2008 Nov; 381(2):251-60. PubMed ID: 18822440
[TBL] [Abstract][Full Text] [Related]
28. Efficient isolation of novel human monoclonal antibodies with neutralizing activity against HIV-1 from transgenic mice expressing human Ig loci.
He Y; Honnen WJ; Krachmarov CP; Burkhart M; Kayman SC; Corvalan J; Pinter A
J Immunol; 2002 Jul; 169(1):595-605. PubMed ID: 12077293
[TBL] [Abstract][Full Text] [Related]
29. Identification of the ligand binding site in Fas (CD95) and analysis of Fas-ligand interactions.
Bajorath J
Proteins; 1999 Jun; 35(4):475-82. PubMed ID: 10382675
[TBL] [Abstract][Full Text] [Related]
30. Molecular cloning, functional characterization, and enzyme-linked immunosorbent assay of cynomolgus monkey Fas ligand.
Kirii Y; Inoue T; Yoshino K; Kayagaki N; Yagita H; Okumura K; Shibata H; Yoshikawa Y; Terao K
J Immunol Methods; 2003 Jul; 278(1-2):201-9. PubMed ID: 12957408
[TBL] [Abstract][Full Text] [Related]
31. Fas/Fas ligand interactions play an essential role in the initiation of murine autoimmune diabetes.
Nakayama M; Nagata M; Yasuda H; Arisawa K; Kotani R; Yamada K; Chowdhury SA; Chakrabarty S; Jin ZZ; Yagita H; Yokono K; Kasuga M
Diabetes; 2002 May; 51(5):1391-7. PubMed ID: 11978635
[TBL] [Abstract][Full Text] [Related]
32. Cloning and expression of a novel murine anti-human Fas antibody.
Yoshida-Kato H; Ichikawa K; Yamaguchi J; Watanabe K; Ohsumi J; Yonehara S; Serizawa N
Biosci Biotechnol Biochem; 2000 Sep; 64(9):1903-8. PubMed ID: 11055394
[TBL] [Abstract][Full Text] [Related]
33. Characterization of Fas (Apo-1, CD95)-Fas ligand interaction.
Schneider P; Bodmer JL; Holler N; Mattmann C; Scuderi P; Terskikh A; Peitsch MC; Tschopp J
J Biol Chem; 1997 Jul; 272(30):18827-33. PubMed ID: 9228058
[TBL] [Abstract][Full Text] [Related]
34. Bioactivities of Fas ligand-expressing retroviral particles.
Jodo S; Strehlow D; Ju ST
J Immunol; 2000 May; 164(10):5062-9. PubMed ID: 10799862
[TBL] [Abstract][Full Text] [Related]
35. Distinct mechanisms of neutralization by monoclonal antibodies specific for sites in the N-terminal or C-terminal domain of murine leukemia virus SU.
Burkhart MD; Kayman SC; He Y; Pinter A
J Virol; 2003 Apr; 77(7):3993-4003. PubMed ID: 12634359
[TBL] [Abstract][Full Text] [Related]
36. Human Fas ligand: gene structure, chromosomal location and species specificity.
Takahashi T; Tanaka M; Inazawa J; Abe T; Suda T; Nagata S
Int Immunol; 1994 Oct; 6(10):1567-74. PubMed ID: 7826947
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Fas- versus perforin-mediated pathways of cytotoxicity in TCR- and Thy-1-activated murine T cells.
Kojima H; Toda M; Sitkovsky MV
Int Immunol; 2000 Mar; 12(3):365-74. PubMed ID: 10700471
[TBL] [Abstract][Full Text] [Related]
38. Characterization of epitopes for neutralizing monoclonal antibodies to classical swine fever virus E2 and Erns using phage-displayed random peptide library.
Zhang F; Yu M; Weiland E; Morrissy C; Zhang N; Westbury H; Wang LF
Arch Virol; 2006 Jan; 151(1):37-54. PubMed ID: 16132176
[TBL] [Abstract][Full Text] [Related]
39. Molecular Characterization of Two Monoclonal Antibodies against the Same Epitope on B-Cell Receptor Associated Protein 31.
Kim WT; Shin S; Hwang HJ; Kim MK; Jung HS; Park H; Ryu CJ
PLoS One; 2016; 11(12):e0167527. PubMed ID: 27907150
[TBL] [Abstract][Full Text] [Related]
40. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
